Sacituzumab Govitecan In TNBC
Conditions
- Invasive Breast Cancer
- Triple Negative Breast Cancer
- ER-Negative Breast Cancer
- PR-Negative Breast Cancer
- HER2-negative Breast Cancer
Interventions
- DRUG: Sacituzumab Govitecan
- DRUG: Pembrolizumab
Sponsor
Massachusetts General Hospital
Collaborators